Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Accolade, Inc is a health information services business based in the US. Accolade shares (ACCD) are listed on the NASDAQ and all prices are listed in US Dollars. Accolade employs 1,230 staff and has a trailing 12-month revenue of around USD$146.8 million.
|Latest market close||USD$41.33|
|52-week range||USD$28.68 - USD$44.955|
|50-day moving average||USD$36.1279|
|200-day moving average||USD$35.081|
|Wall St. target price||USD$41.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.4291|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-14)||-7.10%|
|1 month (2020-09-21)||38.09%|
|3 months (2020-07-21)||28.04%|
|6 months (2020-04-18)||N/A|
|1 year (2019-10-18)||N/A|
|2 years (2018-10-18)||N/A|
|3 years (2017-10-18)||N/A|
|5 years (2015-10-18)||N/A|
|Revenue TTM||USD$146.8 million|
|Gross profit TTM||USD$59.4 million|
|Return on assets TTM||-42.84%|
|Return on equity TTM||0%|
|Market capitalisation||USD$1.9 billion|
TTM: trailing 12 months
There are currently 2.7 million Accolade shares held short by investors – that's known as Accolade's "short interest". This figure is 47.6% up from 1.9 million last month.
There are a few different ways that this level of interest in shorting Accolade shares can be evaluated.
Accolade's "short interest ratio" (SIR) is the quantity of Accolade shares currently shorted divided by the average quantity of Accolade shares traded daily (recently around 340909.80148883). Accolade's SIR currently stands at 8.06. In other words for every 100,000 Accolade shares traded daily on the market, roughly 8060 shares are currently held short.
However Accolade's short interest can also be evaluated against the total number of Accolade shares, or, against the total number of tradable Accolade shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accolade's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Accolade shares in existence, roughly 60 shares are currently held short) or 0.096% of the tradable shares (for every 100,000 tradable Accolade shares, roughly 96 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Accolade.
Find out more about how you can short Accolade stock.
We're not expecting Accolade to pay a dividend over the next 12 months.
Accolade, Inc. develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. Its customers are primarily employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Steps to owning and managing MHO, with 24-hour and historical pricing before you buy.
Steps to owning and managing HLIT, with 24-hour and historical pricing before you buy.
Steps to owning and managing XELA, with 24-hour and historical pricing before you buy.
Steps to owning and managing PDD, with 24-hour and historical pricing before you buy.
Steps to owning and managing JAKK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IMMU, with 24-hour and historical pricing before you buy.
Steps to owning and managing PRCP, with 24-hour and historical pricing before you buy.
Steps to owning and managing MNRO, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMRX, with 24-hour and historical pricing before you buy.
Steps to owning and managing YUM, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.